Santen Pharmaceutical Co (SNPHY): Eigentümerstruktur
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Santen Pharmaceutical Co
Mitarbeiter 3.968
Handelsplatz PINK
Ticker Symbol SNPHY
IPO Datum -
Adresse Grand Front Osaka Tower A, Kita, Japan, 530-8552
Webseite https://www.santen.com/en
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Takeshi Ito | President, CEO & Representative Director |
| 2 | Ms. Rie Nakajima | COO & Director |
| 3 | Mr. Kazuo Koshiji | CFO & Corporate Officer |
| 4 | Mr. Daisuke Nakata | Chief Digital & Information Officer |
| 5 | Ms. Kaori Itagaki | General Manager of Investor Relations Group |
| 6 | Ms. Mika Masunari | Corporate Officer, General Counsel, Chief Risk Officer & Chief Compliance Officer |
| 7 | Ms. Marianthi Psacha | Corporate Officer, Head of EMEA Business and International Pricing Market Access & Public Affairs |
| 8 | Mr. Shinichi Teramachi | Corp. Officer, Head of Sales and Head of Japan Sales & Marketing |
| 9 | Ms. Yoko Saiki | Corporate Officer & Chief Human Resources Officer |
| 10 | Mr. Kenji Morishima | Corporate Officer & Head of China Product Development Department |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu den institutionellen Investoren vor.